
Michel Prazeres Accepts Sanction for Second Violation of UFC Anti-Doping Policy
Michael Prazeres, of Pará, Brazil, has accepted a four-year sanction for his second violation of the UFC® Anti-Doping Policy.
U.S. Anti-Doping Agency (USADA)
Click here to log in to the
Athlete Connect application
Click here to view your
test history and results
Michael Prazeres, of Pará, Brazil, has accepted a four-year sanction for his second violation of the UFC® Anti-Doping Policy.
Drug-tested athletes can learn more about the prohibited status of bioidentical hormones and pellet therapy here.
Grace Bowlby, of Edina, Minn., an athlete in the sport of ice hockey, has accepted a public warning for failing to obtain a TUE prior to her use of an otherwise prohibited medication.
Amara Mbionwu knows supplements are not meant to replace whole foods, but to supplement nutrients that you may be missing from a diet.
USADA CEO Travis T. Tygart comments on HISA Announcement of Proposed Implementation Date for Anti-Doping and Medication Control Program.
Trey Lampkin, of Toledo, Ohio, an athlete in the sport of Paralympic judo, has accepted a public warning for failing to obtain a Therapeutic Use Exemption.
Madeline Wethington, of Edina, Minn., an athlete in the sport of ice hockey, has accepted a public warning for failing to obtain a Therapeutic Use Exemption prior to her use of an otherwise prohibited medication.
Jordan Adel, of McKinney, Texas, an athlete in the sport of weightlifting, has accepted a three-year period of ineligibility for an anti-doping rule violation.
Noah Webb, of Los Angeles, Calif., an athlete in the sport of triathlon, has accepted a four-year period of ineligibility for an anti-doping rule violation.
To better understand how you use our websites and services and to offer you a personalized experience, this website uses first and third-party cookies and tracking technologies deployed by us and our third-party partners. You can opt-out of personalization, analytics and online tracking by clicking “Reject” or managing your cookie preferences through “Customize.” By using our website, you agree to our website Terms of Use (including the class action waiver and arbitration provisions) and Privacy Policy, which have recently changed.
This is an necessary category.